miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer

Gallbladder cancer represents the most common malignancy of the biliary tract and is highly lethal with less than 5% overall 5-year survival rate. Chemotherapy remains the major treatment for late-stage patients. However, insensitivity to these chemotherapeutic agents including cisplatin is common....

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Dong, Zhan, Ming, Chen, Tao, Chen, Wei, Zhang, Yunhe, Xu, Sunwang, Yan, Jinchun, Huang, Qihong, Wang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335654/
https://www.ncbi.nlm.nih.gov/pubmed/28256505
http://dx.doi.org/10.1038/srep43109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335654/
https://www.ncbi.nlm.nih.gov/pubmed/28256505
http://dx.doi.org/10.1038/srep43109

Ejemplares similares